![]() | Darin S CarrollShow email addressCenters for Disease Control & Prevention (CDC), Atlanta, GA 30333, USA;, dellerson@cdc.gov, (D.E.);, dcarroll@cdc.gov, (D.C.) | Division of Scientific Resources, Centers for ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Darin S Carroll:Expert Impact
Concepts for whichDarin S Carrollhas direct influence:Monkeypox virus,Congo basin,Prairie dogs,North america,Akhmeta virus,Human monkeypox,Democratic republic,Vaccinia virus.
Darin S Carroll:KOL impact
Concepts related to the work of other authors for whichfor which Darin S Carroll has influence:Nipah virus,United states,Human monkeypox,Democratic republic,Healthcare workers,Public health,Smallpox vaccine.
KOL Resume for Darin S Carroll
Year | |
---|---|
2021 | Centers for Disease Control & Prevention (CDC), Atlanta, GA 30333, USA;, (D.E.);, (D.C.) |
2020 | Centers for Disease Control and Prevention, COVID-19 Response Team, Atlanta, Georgia, USA |
2019 | U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia, USA. Centers for Disease Control and Prevention, The University of Georgia, Athens, Georgia. |
2018 | Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers of Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA;, (J.G.);, (C.G.);, (P.L.);, (S.T.);, (K.W.);, (K.Z.);, (W.D.);, (Y.N.);, (D.S.C.);, (G.E.) |
2017 | Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA;, (G.L.E.);, (Y.L.);, (D.S.C.) International Conservation Education Fund, Washington, D.C., United States of America Divisions of High-Consequence Pathogens and Pathology, Tbilisi, Georgia. The National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention, Atlanta, GA, USA |
2016 | Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, Georgia 30333, USA The National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia |
2015 | Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA Department of Environmental Sciences, Emory University, Atlanta, GA, United States |
2014 | Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30333, USA Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia |
2013 | Poxvirus and Rabies Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA |
2012 | Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America Department of Biological Sciences, Texas Tech University, Lubbock, Texas. |
2011 | Poxvirus Program, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
2010 | Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA |
2009 | Centers for Disease Control and Prevention, MS G-43, 1600 Clifton Road NE, Atlanta, GA 30333, USA. National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Impfondo, Atlanta, Georgia |
2008 | Centers for Disease Control and Prevention, Atlanta, Georgia |
2007 | Centers for Disease Control and Prevention, Atlanta, GA 30333, USA (DSC) |
2006 | Pox Virus Branch, Center for Disease Control, Atlanta, GA 30333 Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA |
2005 | Division of Viral and Rickettsial Diseases, Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409-3131 Present address for DSC: Center for Disease Control, 100 Clifton Road, Atlanta, GA 30333 |
2004 | Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409-3131, USA (RDB, DSC, MLH) Present address of DSC: Center for Disease Control, 1600 Clifton Road, Atlanta, GA 30333, USA |
2000 | Department of Biology, Angelo State University, San Angelo, TX 76909, USA. Current address: Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA, . |
Concept | World rank |
---|---|
case akhmeta | #1 |
orthopoxvirus mexican | #1 |
neotomini peromyscini | #1 |
wb western blot | #1 |
mpxv infected | #1 |
endemic orthopoxvirus | #1 |
woodrats infections | #1 |
3330 rodents strains | #1 |
opxv antibody prevalence | #1 |
southern texas 2001–2004 | #1 |
virus catarina | #1 |
antibody catarina virus | #1 |
texas antibody | #1 |
elisa procyonidae | #1 |
30 n366 | #1 |
population recovery increase | #1 |
evidence opxv | #1 |
texas neotoma | #1 |
antibody prevalence 30 | #1 |
procyonidae mexico | #1 |
enm potential distribution | #1 |
human tanapox | #1 |
analgesia mpxv challenge | #1 |
varv animal | #1 |
serum akhmeta | #1 |
factors mpxv | #1 |
june catarina | #1 |
tanapox enm | #1 |
mpxv experience | #1 |
catarina virus infection | #1 |
virus tanapox | #1 |
unique individuals drought | #1 |
congo mpxv | #1 |
orthopoxviruses opxv | #1 |
akhmeta virus infection | #1 |
medical prophylaxes | #1 |
durango sinaloa | #1 |
susceptible varv | #1 |
serum mexican | #1 |
peromyscine rodent | #1 |
july average precipitation | #1 |
congo monkeypox virus | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by Darin S Carroll
Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020
[ PUBLICATION ]
Abstract Importance Reported cases of SARS-CoV-2 infection likely underestimate the prevalence of infection in affected communities. Large-scale seroprevalence studies provide better estimates of the proportion of the population previously infected. Objective To estimate prevalence of SARS-CoV-2 antibodies in convenience samples from several geographic sites in the United States. Design Serologic testing of convenience samples using residual sera obtained for routine clinical ...
Known for United States | Reported Cases | March 23 | Site Seroprevalence | Estimates Proportion |
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
[ PUBLICATION ]
Importance: Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection likely underestimate the prevalence of infection in affected communities. Large-scale seroprevalence studies provide better estimates of the proportion of the population previously infected.
Objective: To estimate prevalence of SARS-CoV-2 antibodies in convenience samples from several geographic sites in the US.
Design, Setting, and Participants: This cross-sectional study performed ...
Known for Reported Cases | United States | New York City | Antibodies Sarscov2 | Washington State |
BACKGROUND: In Bangladesh, 4 outbreaks of Nipah virus infection were identified during the period 2001-2004.
METHODS: We characterized the clinical features of Nipah virus-infected individuals affected by these outbreaks. We classified patients as having confirmed cases of Nipah virus infection if they had antibodies reactive with Nipah virus antigen. Patients were considered to have probable cases of Nipah virus infection if they had symptoms consistent with Nipah virus infection during ...
Known for Nipah Virus Infection | Clinical Characteristics | Probable Cases | Respiratory Difficulty | Bangladesh Child |
Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus
[ PUBLICATION ]
Smallpox preparedness research has led to development of antiviral therapies for treatment of serious orthopoxvirus infections. Monkeypox virus is an emerging, zoonotic orthopoxvirus which can cause severe and transmissible disease in humans, generating concerns for public health. Monkeypox virus infection results in a systemic, febrile-rash illness closely resembling smallpox. Currently, there are no small-molecule antiviral therapeutics approved to treat orthopoxvirus infections of ...
Known for Monkeypox Virus | Prairie Dogs | Viral Disease Models | Animals Treatment | Public Health |
Monkeypox virus, a zoonotic member of the genus Orthopoxviridae, can cause a severe, smallpox-like illness in humans. Monkeypox virus is thought to be endemic to forested areas of western and Central Africa. Considerably more is known about human monkeypox disease occurrence than about natural sylvatic cycles of this virus in non-human animal hosts. We use human monkeypox case data from Africa for 1970-2003 in an ecological niche modeling framework to construct predictive models of the ...
Known for Human Monkeypox | Geographic Distribution | Ecological Niche | Central Africa | Forested Areas |
A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus
[ PUBLICATION ]
Multiple monkeypox virus (MPXV) animal models have been discussed in previous studies, but no small animal models, nor most non-human primate models, demonstrated the protracted asymptomatic incubation phase seen in systemic human orthopoxvirus illness. Herein, we characterize a black-tailed prairie dog (PD) (Cynomys ludovicianus) model of infection, via intranasal and intradermal exposures, with the two MPXV clades. Daily observations of the animals were made (food consumption, general ...
Known for Monkeypox Virus | Animal Model | Congo Basin | Mpxv Clades | Disease Presentation |
Assessing Monkeypox Virus Prevalence in Small Mammals at the Human–Animal Interface in the Democratic Republic of the Congo
[ PUBLICATION ]
During 2012, 2013 and 2015, we collected small mammals within 25 km of the town of Boende in Tshuapa Province, the Democratic Republic of the Congo. The prevalence of monkeypox virus (MPXV) in this area is unknown; however, cases of human infection were previously confirmed near these collection sites. Samples were collected from 353 mammals (rodents, shrews, pangolins, elephant shrews, a potamogale, and a hyrax). Some rodents and shrews were captured from houses where human monkeypox ...
Known for Democratic Republic | Monkeypox Virus | Small Mammals | Tshuapa Province | Immunosorbent Assay |
Laboratory Investigations of African Pouched Rats (Cricetomys gambianus) as a Potential Reservoir Host Species for Monkeypox Virus
[ PUBLICATION ]
Monkeypox is a zoonotic disease endemic to central and western Africa, where it is a major public health concern. Although Monkeypox virus (MPXV) and monkeypox disease in humans have been well characterized, little is known about its natural history, or its maintenance in animal populations of sylvatic reservoir(s). In 2003, several species of rodents imported from Ghana were involved in a monkeypox outbreak in the United States with individuals of three African rodent genera ...
Known for Monkeypox Virus | Gambian Rats | Host Species | Mpxv Infection | Zoonotic Disease |
Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox)
[ PUBLICATION ]
Naturally occurring smallpox has been eradicated but remains a considerable threat as a biowarfare/bioterrorist weapon (F. Fleck, Bull. World Health Organ. 81:917-918, 2003). While effective, the smallpox vaccine is currently not recommended for routine use in the general public due to safety concerns (http://www.bt.cdc.gov/agent/smallpox/vaccination). Safe and effective countermeasures, particularly those effective after exposure to smallpox, are needed. Currently, SIGA Technologies is ...
Known for Nonhuman Primates | Smallpox Tecovirimat | Variola Virus | General Public | Siga Technologies |
Adverse Events Post Smallpox-Vaccination: Insights from Tail Scarification Infection in Mice with Vaccinia virus
[ PUBLICATION ]
Adverse events upon smallpox vaccination with fully-replicative strains of Vaccinia virus (VACV) comprise an array of clinical manifestations that occur primarily in immunocompromised patients leading to significant host morbidity/mortality. The expansion of immune-suppressed populations and the possible release of Variola virus as a bioterrorist act have given rise to concerns over vaccination complications should more widespread vaccination be reinitiated. Our goal was to evaluate the ...
Known for Vaccinia Virus | Tail Scarification | Infection Mice | Positive Lymphocytes | Murine Model |
Although the World Health Organization (WHO) declared global smallpox eradicated in 1980, concerns over emergent poxvirus infections have increased. Most poxvirus infections are zoonotic; exploring their genetic diversity will illuminate the genetic and evolutionary aspects of poxvirus infections, ecology, and epidemiology. In recent decades, several strains of the orthopoxvirus vaccinia virus (VACV) have been isolated throughout Brazil, including genetically distinct isolates within the ...
Known for Brazilian Vaccinia | Molecular Data | Health Organization | Genetic Variation | Sequence Brazil |
Human monkeypox has never been reported in Ghana, but rodents captured in forested areas of southern Ghana were the source of the monkeypox virus introduced into the United States in 2003. Subsequent to the outbreak in the United States, 204 animals were collected from two commercial trapping sites in Ghana. Animal tissues were examined for the presence of orthopoxvirus (OPXV) DNA using a real-time polymerase chain reaction, and sera were assayed for antibodies against OPXV. Animals from ...
Known for West Africa | United States | Opxv Dna | Human Monkeypox | Animals Antibodies |
Comparison of West African and Congo Basin Monkeypox Viruses in BALB/c and C57BL/6 Mice
[ PUBLICATION ]
Although monkeypox virus (MPXV) studies in wild rodents and non-human primates have generated important knowledge regarding MPXV pathogenesis and inferences about disease transmission, it might be easier to dissect the importance of virulence factors and correlates of protection to MPXV in an inbred mouse model. Herein, we compared the two clades of MPXV via two routes of infection in the BALB/c and C57BL/6 inbred mice strains. Our studies show that similar to previous animal studies, ...
Known for Congo Basin | West African | Monkeypox Virus | Inbred Balb Mice | C57bl 6 |
Characterization of monkeypox virus infection in African rope squirrels (Funisciurus sp.)
[ PUBLICATION ]
Monkeypox (MPX) is a zoonotic disease endemic in Central and West Africa and is caused by Monkeypox virus (MPXV), the most virulent Orthopoxvirus affecting humans since the eradication of Variola virus (VARV). Many aspects of the MPXV transmission cycle, including the natural host of the virus, remain unknown. African rope squirrels (Funisciurus spp.) are considered potential reservoirs of MPXV, as serosurveillance data in Central Africa has confirmed the circulation of the virus in ...
Known for Monkeypox Virus | Central Africa | Viral Humans | Zoonotic Disease | Mpxv Infection |
Further Assessment of Monkeypox Virus Infection in Gambian Pouched Rats (Cricetomys gambianus) Using In Vivo Bioluminescent Imaging
[ PUBLICATION ]
Monkeypox is a zoonosis clinically similar to smallpox in humans. Recent evidence has shown a potential risk of increased incidence in central Africa. Despite attempts to isolate the virus from wild rodents and other small mammals, no reservoir host has been identified. In 2003, Monkeypox virus (MPXV) was accidentally introduced into the U.S. via the pet trade and was associated with the Gambian pouched rat (Cricetomys gambianus). Therefore, we investigated the potential reservoir ...
Known for Monkeypox Virus | Vivo Bioluminescent | Central Africa | Pet Trade | Clinical Signs |